AzTrials
AzTrials

Mental ImageryNCT05232526

Imagery in Early Stages of Dementia

A study testing Mental imagery (MI) and exercise program and Mental Imagery and Exercise program in people with Mental Imagery and Dementia of Alzheimer Type, run by University of West Attica at 1 site in Greece.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of the present study is to investigate the effectiveness of mental imagery (MI) in subjects with early stage of dementia. The hypothesis of the study is that MI will have a beneficial effect in motor, cognitive and emotional state in this clinical population. Read more about this study

Who is it for?
Ages 65 to 95 yearsHealthy volunteers can take part
Conditions the study is for
Mental Imagery, Dementia of Alzheimer Type
What is being tested?
Mental imagery (MI) and exercise program and Mental Imagery and Exercise program
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
105 participants
Where
1 siteGreece
Study dates
10 Oct 2021to 10 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 95 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • 95 years<age>65 years
  • Diagnosed early stage of dementia
  • Good oral and written speech and to perform orders
  • Both sexes
  • Ambulatory
  • No other health issues in the last month

Who cannot join

  • Late stage of dementia
  • Psychiatric problems
  • Serious health problems
  • Not able to walk

Trial locations and contacts

1 site in 1 country.

Anna Christakou, PhD contact

+306977370284

achristakou@uniwa.gr

Vasiliki Sakellari, Pr contact

+306979033952

vsakellari@uniwa.gr

Greece1 site, 1 recruiting
  • University of West Attica

    Athens, Aigaleo, 12243

    Anna Christakou, PhD, +306977370284, achristakou@uniwa.gr

    Vasiliki Sakellari, Pr, +306979033952, vsakellari@uniwa.gr

    Recruiting

Other trials in Greece

About this study

Official title: The Effectiveness of Mental Imagery in Motor and Cognitive Rehabilitation in Subjects of Early Stage of Dementia

The purpose of the present study is to investigate the effectiveness of mental imagery (MI) in subjects with early stage of dementia. The hypothesis of the study is that MI will have a beneficial effect in motor, cognitive and emotional state in this clinical population.

Read the detailed description

Dementia is a disorder that is characterized by a decline in cognition involving one or more cognitive domains (learning and memory, language, executive function, complex attention, perceptual-motor, social cognition). The most common form of dementia in older adults is Alzheimer disease (AD), accounting for 60 to 80 percent of cases.

Mental imagery (MI) is a technique which involves envisioning motor actions without actual execution. MI is considered an effective rehabilitative tool in athletes, Parkinson's disease, and post stroke because it engages the same or similar neural systems as the actual execution of motor actions to improve gait, gait-related, and cognitive functions having as a result improvements in gait speed, stride length, tandem stance, timed up and go, clock drawing and stroop interference.

The recruitment of the population will be carried out by Day Care Centers in Athens Alzheimer Association. A group of elderly patients with early stage of dementia, aged 65 to 95 years, will participate. Information sheet and consent form will be provided to all participants. A randomized intervention study is designed to assess the efficacy of MI as therapeutic strategy for subjects with early stage of dementia and the sample will be randomized to one of the three following study groups: 1. MI and exercise program (intervention group) 2. Only exercise program (control group) 3. Neither MI nor exercise program (2nd control group). Assessment will be obtained in three-time periods: prior to the program, middle of the program and after the program.

Being tested
Mental imagery (MI) and exercise program, Mental Imagery and Exercise program
Keywords
Imagery, Exercise, Dementia
Medical subject headings
Motor Activity, Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mental imagery (MI) and exercise programOther

    Mental imagery and exercise program will be used to improve balance, functional status, cognitive ability, depression and quality of life of the sample

  • Mental Imagery and Exercise programDevice

    Questionnaires and functional tests are going to be used to evaluate balance, functional status, cognitive ability, depression and quality of life of the sample.

Study groups in NCT05232526
Study groupRoleWhat they receive
Mental imagery (MI) and exercise programExperimentalMI will start immediately when the sample is going to start the exercise program. The intervention group will undergo 24 sessions of imagery, starting from the 1st exercise program session. Participants of the intervention group will undergo a 45-minute imagery session sitting in a quiet place after the end of every exercise program session. The content of every imagery session is alike with the content of the exercise program session. That means that every session includes imagery of the same exercises of the exercise program performed earlier by the subject in the Day Center. Sessions are identical for all subjects of the intervention group. The total duration of the physiotherapy exercise program will be 24 sessions, 2 times/week, duration of 45 minutes each session, 3 months (12 weeks).
Receives: Other: Mental imagery (MI) and exercise program; Device: Mental Imagery and Exercise program
Exercise programPlacebo comparatorThe total duration of the physiotherapy exercise program will be 24 sessions, 2 times/week, duration of 45 minutes each session, 3 months (12 weeks).
Receives: Other: Mental imagery (MI) and exercise program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change is being assessed (Change from Baseline Balance at 12 weeks)

    The Berg Balance Scale (BBS) is used to objectively determine a subject's ability to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a 5-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.

    Measured: Prior to the 1st week of the program, the 12th week of the program

  2. Change is being assessed (Change from Baseline Stability at 12 weeks)

    The Multidirectional Reach Test (Reach in Four Directions Test) is a screening tool to determine the limits of stability of subjects in 4 directions: forward, backward, leftward and rightward. Subjects performed maximal outstretched arm reach in each direction with their feet flat on the floor.

    Measured: Prior to the 1st week of the program, the 12th week of the program

  3. Change is being assessed (Change from Baseline Siti-to-stand ability at 12weeks)

    The Five Times Sit-to-Stand Test (FTSST) is considered to be a useful, consistent and low-cost tool to assess sit-to-stand ability. The FTSST measures the time taken to stand five times from a sitting position as quickly as possible that measures of lower limb strength, balance control and exercise capacity.

    Measured: Prior to the 1st week of the program, the 12th week of the program

  4. Change is being assessed (Change from Baseline Functional status at 12 weeks)

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility. It measures the time that a subject takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees.

    Measured: Prior to the 1st week of the program, the 12th week of the program

Secondary outcomes (3)
  1. Cognitive ability

    The Walking While Talking Test (WWITT) is a dual-task measure to examine cognitive-motor interactions. During the WWTT, subjects walk at self-paced speed for 6 meters before turning and walking back to the starting point. During the walking subjects recite 12 Greek alphabet letters (each letter at each step) starting with "A" (ΑΒΓΔ, ΚΛΜΝ, ΠΡΣΤ) until the starting point. Time and errors in the alphabet will be recorded.

    Measured: Prior to the 1st week of the program, the 6th week of the program, the 12th week of the program

  2. Depression

    The Short-Form of Geriatric Depression Scale (SF-GDS) is a 15-question screening tool for depression in older adults, using a "Yes/No" format. It takes 5-7 minutes to complete and is filled out by the researcher with minimal training in its use.

    Measured: Prior to the 1st week of the program, the 6th week of the program, the 12th week of the program

  3. Quality of life

    The Euro-Qol 5 Dimensions 5 Level of severity scale (Euro-Qol 5D-5L scale) is a preference-based Health Related Quality of Life measure which includes 5 domains, i.e., mobility, self-care, usual activities, pain/discomfort, anxiety/depression. The core of all domains ranges from 1 (best score) up to 5 (worse score). The total perceived quality of life will be graded by the patient. Also it includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).

    Measured: Prior to the 6th week of the program, the 6th week of the program, the 12th week of the program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2022
  2. Study start10 Oct 2021
  3. Primary completion1 Jun 2024 (estimated)
  4. Study completion10 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05232526
Sponsor's protocol ID
93292 - 26/10/2021
Status last verified
Jan 2022
First submitted
13 Jan 2022
Last updated
10 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Christakou A, Bouzineki C, Pavlou M, Stranjalis G, Sakellari V. The effectiveness of mental imagery on motor, cognitive and emotional status of older people with early-stage dementia: A study protocol. J Frailty Sarcopenia Falls. 2023 Mar 1;8(1):60-65. doi: 10.22540/JFSF-08-060. eCollection 2023 Mar.

    PubMed 36873828

Questions about this trial

What is this clinical trial studying?

A study testing Mental imagery (MI) and exercise program and Mental Imagery and Exercise program in people with Mental Imagery and Dementia of Alzheimer Type, run by University of West Attica at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anna Christakou, PhD (+306977370284, achristakou@uniwa.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change is being assessed (Change from Baseline Balance at 12 weeks) (time frame: Prior to the 1st week of the program, the 12th week of the program). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05232526, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in